Table Of Content

Author index Payne L.G. 52 Schneemann M. 431 Urosevic N. 224 Peachman K.K. 415 Schoedon G. 431 Pererva N. 192 Schwarz K. 130 Vasconcelos J.R.C. 121 Petrovsky N. 137 Scicchitano R. 289 Veale M. F. 297 Pietersz G.A. 79 Sedgmen B. J. 305 Vinay D.S. 176 Plebanski M. 79 Selmeczy Z. 472 VisiE.S. 472 Proft T. 237 Silva D. 137 Simeonovic C. 160 Walker J.G. 409 Ralph S.J. 459 Simmons P. J. 311 Ward S.M. 73 RaoM. 415 Simon-Chazottes D. Warren H. 498 Razzak M. 185 Singh M. B. 86 Weeratna R. 59 Rebollo A. 171 Slobbe L. 185 Wicks 1.P. 354 Reefman E. 382 Smyth M. 332 Willenborg D.O. 237 Regner M. 217 SochaL. 137 Williams K.A. 93 Reich M.B. 440 Staege M.S. 266 Williamson P. 343 Reske-Junz A.B. 266 Stock O. 67 Wilson H.L. 144 Reynolds P.N. 289 Suganuma N. 335 Wilson H.L. 239 Rizkalla M. 67 Sugaya H. 275 Wintergerst U. 130 Roberton D. M. 163 Sullivan J.S. 192 WolisiG.O. 176 Roberts L. J. 354 Szelényi J. 472 Wong M. 192 Roberts-Thomson P. J. 409 Wykes M. 328 Rocheleau J. V. 440 Takahashi N. 275 Rodda S.J. 1 Tan Sardjono C. 374 Young !1.G. 332 Rodrigues M.M. 121 Terao T. 335 Yu K-Y. 176 Rodriguez-Sosa M. 114 Terrazas L. 1. 114 Yuan FF. 192 Rosas L.E. 114 Thiel M.A. 93 Rothwell S.W. 415 Thomas H.E. 451 Zannettino A. 31 Thomas J. W. 440 Zeng W. 67 Sasaki H. 275 Tindle R. W. 1 Zhan Y. 451 SatoY . 275 Tindle R. W. 73 Zhong J. 480 SatoskarA.R. 114 Torresi J. 63 Zola H. 163 SchaffnerA . 431 Torresi J. 67 ZulegerC.L. 52 Schiffer M. 152 Triccas J. 333 Schmitt C. 171 Tuckerl. 185 Immunology and Cell Biology (2003) 81, 502-507 Subject index 2’-5’ oligoadenylate synthetase B interferon type I and flavivirus resistance 224 B cells 3-dioxygenase why do B cells produce CD40 ligand? 328 tryptophan and the immune response 247 bacteria 4-1BB bacterial otitis media 46 immune responses in 4-1BB’"CD28°" mice 176 B-cell lymphona-2 T-cell apoptosis in Mycobacterium avium infection 480 A bronchial epithelial cell acute lumphoblastic leukaemia deficient phagocytosis in the airways in chronic CD44 antibody recognizes malignant pre-B acute obstructive pulmonary disease 289 lymphoblastic leukaemia 311 adaptive immunity Cc cancer immunotherapy 106 calcium signalling adhesion signalling in mutant B lymphoma lines 297 CD44 antibody recognizes malignant pre-B acute cancer immunotherapy lymphoblastic leukaemia 311 cancer immunotherapy 106 leucocyte recruitment in systemic lupus erythematosus- CC chemokine receptor | prone mice 390 CC chemokine receptor | mediating susceptibility to Aiolos Leishmania major 114 Ikaros proteins and malignancies 171 CD28 alum immune responses in 4-1BB’*"CD28*- mice 176 epidermal powder immunization, hepatitis B surface CD4 antigen 52 requirements for interleukin-4 induction 283 alveolar macrophage CD40 ligand deficient phagocytosis in the airways in chronic why do B cells produce CD40 ligand? 328 obstructive pulmonary disease 289 CD44 animal models CD44 antibody recognizes malignant pre-B acute molecular targets in rheumatoid arthritis 354 lymphoblastic leukaemia 311 antibody cell adhesion molecules immunization using poly s-caprolactone microparticles flavivirus decoys the immune response 207 185 cell culture antibody-secreting cells in vitro development of dendritic cells 144 optimisation of an ovine antibody-secreting cell culture cell cycle assay 305 interleukin-2 receptor signalling 343 antigen dose cell development reducing antigen dose with cystosine guanine dinucleotide- murine dendritic cells development 239 containing oligodeoxynucleotide as adjuvant 59 cell isolation antigen presentation isolation of antigen-specific B cells 163 cytotoxic T lymphocyte responses to melanoma cell cell polarization vaccines 459 X-linked thrombocytopenia macrophages show interleukin-2 prolongs postactivational refractoriness 8 attenuated Wiskott-Aldrich syndrome antigen presenting cells phenotype 130 aspects of cancer immunotherapy 79 cell-mediated immunity antigen-specific B cell immunization using poly ¢-caprolactone microparticles isolation of antigen-specific B cells 163 185 antiviral signalling pathways cholesterol interferon type I and flavivirus resistance 224 cholesterol and intracellular trafficking 415 apoptosis chronic granulomatous disease deficient phagocytosis in the airways in chronic differentiation and tumour necrosis factor-a in PLB obstructive pulmonary disease 289 chronic granulomatous disease cells 472 in vitro development of dendritic cells 144 circadian apoptosis circadian macrophage inhibitory factor rhythm 137 T-cell apoptosis in Mycobacterium avium infection 480 corneal transplantation autoimmune disease antibody therapy for corneal transplantation 93 drug treatment for rheumatoid arthritis and systemic cortisol lupus erythematosus 350 circadian macrophage inhibitory factor rhythm 137 autoimmunity costimulation Fcy receptors and systemic lupus erythematosus 382 cytotoxic T lymphocyte responses to melanoma cell molecular targets in rheumatoid arthritis 354 vaccines 459 Subject index costimulation Expanded Programme on Immunization immune responses in 4-1BB°*-CD28*- mice 176 global immunization programmes 20 CpG experimental autoimmune encephalomyelitis epidermal powder immunization, hepatitis B surface interleukin-2 prolongs postactivational refractoriness antigen 52 expression CpG-containing oligodeoxynucleotide mucosal vascular addressin cell adhesion molecule-| reducing antigen dose with cystosine guanine outside the endothelial lineage 320 dinucleotide-containing oligodeoxynucleotide as adjuvant 59 F cytokine blockade Fas molecular targets in rheumatoid arthritis 354 FasL cytokines T-cell apoptosis in Mycobacterium avium infection 480 circadian macrophage inhibitory factor rhythm 137 Fe receptors MUC2 mRNA through mitogen-activated protein kinase FcyRIla as an inflammatory mediator 374 pathway 275 Fey receptors cytotoxic T lymphocyte responses to melanoma cell Fcy receptors and systemic lupus erythematosus 382 vaccines 459 FeyRIA epidermal powder immunization, hepatitis B surface FcyRIIA genotypes and streptococcus pneumoniae 192 antigen 52 fibroblast listeria species and interleukin-4 deactivation 431 mucosal vascular addressin cell adhesion molecule-| cytotoxic T lymphocyte epitope determination outside the endothelial lineage 320 determination of cytotoxic T lymphocyte epitopes 1 flavivirus resistance factor cytotoxic T lymphocyte responses interferon type I and flavivirus resistance 224 cytotoxic T lymphocyte responses to melanoma cell flavivirus vaccines 459 flavivirus decoys the immune response 207 cytotoxic T lymphocyte major histocompatibility complex class | up-regulation determination of cytotoxic T lymphocyte epitopes | by flaviviruses 217 : Kunjin replicon ribonucleic acid as a vaccine 73 oligoadenylate synthetase 1b protein provides protection cytotoxic T-cells against West Nile virus 230 reciprocal lysis of cytotoxic T-cells 266 flow cytometry deficient phagocytosis in the airways in chronic obstructive pulmonary disease 289 D isolation of antigen-specific B cells 163 delayed-type hypersensitivity interleukin-4 suppresses induction of early delayed type G hypersensitivity 424 genetic determinism dendritic cell maturation oligoadenylate synthetase |b protein provides protection lipopeptide-induced maturation of dendritic cells 67 against West Nile virus 230 dendritic cells genotype tryptophan and the immune response 247 FceyRIIA genotypes and streptococcus pneumoniae 192 aspects of cancer immunotherapy 79 germinal centre immune response in hepatitis C virus infection 63 why do B cells produce CD40 ligand? 328 in vitro development of dendritic cells 144 Global Alliance for Vaccines and Immunization lipopeptide-induced maturation of dendritic cells 67 global immunization programmes 20 murine dendritic cells development 239 graft rejection differentiation antibody therapy for corneal transplantation 93 differentiation and tumour necrosis factor-a in PLB grass pollen allergy chronic granulomatous disease cells 472 grass pollen immunotherapy vaccines 86 diurnal growth factors circadian macrophage inhibitory factor rhythm 137 fibroblast growth factor receptor interaction with Lck DNA immunization and nuclear factor of activated T cells 440 DNA-priming protein-boosting immunization 121 improving vaccines against tuberculosis 34 H H-2K° E aspects of cancer immunotherapy 79 electron microscopy haematopoiesis plasma cells in rat yolk sac 335 in vitro development of dendritic cells 144 ELISPOT haemopoiesis determination of cytotoxic T lymphocyte epitopes | murine dendritic cells development 239 encephalitis hay fever flavivirus evasion of the immune system 196 grass pollen immunotherapy vaccines 86 Subject index Helios innate immunity Ikaros proteins and malignancies 171 cancer immunotherapy 106 hepatitis B surface antigen listeria species and interleukin-4 deactivation 431 epidermal powder immunization, hepatitis B surface innate susceptibility antigen 52 oligoadenylate synthetase |b protein provides protection hepatitis B against West Nile virus 230 epidermal powder immunization, hepatitis B surface interferon type I antigen 52 interferon type I and flavivirus resistance 224 hepatitis C virus interferons immune response in hepatitis C virus infection 63 oligoadenylate synthetase 1b protein provides protection Kunjin replicon ribonucleic acid as a vaccine 73 against West Nile virus 230 lipopeptide-induced maturation of dendritic cells 67 cytotoxic T lymphocyte responses to melanoma cell HT29 cell vaccines 459 MUC2 mRNA through mitogen-activated protein kinase interferon-y pathway 275 immunization using poly ¢-caprolactone microparticles human papillomavirus 185 determination of cytotoxic T lymphocyte epitopes 1 interleukin-16 hyaluronic acid requirements for interleukin-4 induction 283 CD44 antibody recognizes malignant pre-B acute interleukin-2 receptor lymphoblastic leukaemia 311 interleukin-2 receptor signalling 343 hypoallergen interleukin-4 grass pollen immunotherapy vaccines 86 interleukin-4 suppresses induction of early delayed type hypersensitivity 424 I listeria species and interleukin-4 deactivation 431 Ikaros requirements for interleukin-4 induction 283 Ikaros proteins and malignancies 171 intracellular trafficking immune escape cholesterol and intracellular trafficking 415 major histocompatibility complex class | up-regulation by flaviviruses 217 K immune evasion Kunjin replicon cancer immunotherapy 106 Kunjin replicon ribonucleic acid as a vaccine 73 immune regulation kynurenine requirements for interleukin-4 induction 283 tryptophan and the immune response 247 immune response flavivirus evasion of the immune system 196 L immune response in hepatitis C virus infection 63 Langerhans cells immunity flavivirus decoys the immune response 207 bacterial otitis media 46 Leishmania major immunization using poly ¢-caprolactone microparticles CC chemokine receptor | mediating susceptibility to 185 Leishmania major 114 imunocontraception leucocyte evolution of immunocontraception resistance 152 integrins and selectins in arthritis 397 immunoglobulin E lineage grass pollen immunotherapy vaccines 86 murine dendritic cells development 239 optimisation of an ovine antibody-secreting cell culture lipopeptides assay 305 lipopeptide-induced maturation of dendritic cells 67 immunohistochemistry liposomes plasma cells in rat yolk sac 335 cholesterol and intracellular trafficking 415 immunomagnetic separation Listeria monocytogenes isolation of antigen-specific B cells 163 listeria species and interleukin-4 deactivation 431 immunosuppression listeriolysin antibody therapy for corneal transplantation 93 listeria species and interleukin-4 deactivation 431 immunosurveillance liver cancer immunotherapy 106 immune response in hepatitis C virus infection 63 immunotherapy LS174T cell grass pollen immunotherapy vaccines 86 MUC2 mRNA through mitogen-activated protein kinase indoleamine 2 pathway 275 tryptophan and the immune response 247 lymphocyte activation inflammation signalling in mutant B lymphoma lines 297 bacterial otitis media 46 lymphocyte integrins and selectins in arthritis 397 integrins and selectins in arthritis 397 Subject index lymphoid malignancies multiple sclerosis Ikaros proteins and malignancies 171 interleukin-2 prolongs postactivational refractoriness 8 lymphoma myc signalling in mutant B lymphoma lines 297 interleukin-2 receptor signalling 343 Mycobacterium avium M T-cell apoptosis in Mycobacterium avium infection machrophage migration inhibitory factor Mycobacterium tuberculosis circadian macrophage inhibitory factor rhythm 137 improving vaccines against tuberculosis 34 macrophage deactivation listeria species and interleukin-4 deactivation 431 N macrophage naive proliferation tryptophan and the immune response 247 thymic output and naive proliferation 487 X-linked thrombocytopenia macrophages show natural killer cell attenuated Wiskott-Aldrich syndrome phenotype 130 major histocompatibility complex class | up-regulation macrophages by flaviviruses 217 innate mechanism in xenograft rejection 451 Neuroendocrine major histocompatibility complex class I circadian macrophage inhibitory factor rhythm 137 aspects of cancer immunotherapy 79 neurone major histocompatibility complex class | up-regulation oligoadenylate synthetase |b protein provides protection by flaviviruses 217 against West Nile virus 230 major histocompatibility complex neutrophil flavivirus decoys the immune response 207 integrins and selectins in arthritis 397 interleukin-2 prolongs postactivational refractoriness 8 niacin melanoma tryptophan and the immune response cytotoxic T lymphocyte responses to melanoma cell nicotinamide adenine dinucleotide vaccines 459 tryptophan and the immune response mucosal vascular addressin cell adhesion molecule-| outside the endothelial lineage 320 O microbial killing oligoadenylate synthetase listeria species and interleukin-4 deactivation 431 oligoadenylate synthetase 1b protein provides protection microcirculation against West Nile virus 230 leucocyte recruitment in systemic lupus erythematosus- otitis media prone mice 390 bacterial otitis media 46 microparticulate delivery immunization using poly e-caprolactone P microparticles 185 pathogenesis migration flavivirus evasion of the immune system 196 integrins and selectins in arthritis 397 peptide-major histocompatibility complex interactions mitogen activated protein kinase signalling aspects of cancer immunotherapy 79 signalling in mutant B lymphoma lines 297 peptide-based vaccines mitogen-activated protein kinase lipopeptide-induced maturation of dendritic cells 67 MUC2 mRNA through mitogen-activated protein kinase peptides pathway 275 determination of cytotoxic T lymphocyte epitopes | mitogens phagocytosis optimisation of an ovine antibody-secreting cell culture cholesterol and intracellular trafficking 415 assay 305 deficient phagocytosis in the airways in chronic monoclonal antibodies obstructive pulmonary disease 289 antibody therapy for corneal transplantation 93 phosphatidylinositol 3-kinase monocyte interleukin-2 receptor signalling 343 integrins and selectins in arthritis 397 plasma cells mouse plasma cells in rat yolk sac 335 oligoadenylate synthetase 1b protein provides protection PLB-985 against West Nile virus 230 differentiation and tumour necrosis factor-a in PLB MUC2 chronic granulomatous disease cells 472 MUC2 messenger RNA through mitogen-activated pneumococcal sepsis protein kinase pathway 275 FcyRIIA genotypes and streptococcus pneumoniae 192 Mucin | podosome aspects of cancer immunotherapy 79 X-linked thrombocytopenia macrophages show mucosal vascular addressin cell adhesion molecule-| attenuated Wiskott-Aldrich syndrome phenotype 130 mucosal vascular addressin cell adhesion molecule-| poly adenosine triphosphate-ribose polymerase outside the endothelial lineage 320 tryptophan and the immune response 247 Subject index poly s-caprolactone systemic lupus erythematosus immunization using poly ¢-caprolactone drug treatment for rheumatoid arthritis and systemic microparticles 185 lupus erythematosus 350 population control Fcy receptors and systemic lupus erythematosus 382 evolution of immunocontraception resistance 152 FcyRIla as an inflammatory mediator 374 prime-boost leucocyte recruitment in systemic lupus erythematosus- improving vaccines against tuberculosis 34 prone mice 390 proliferation IL-2 receptor signalling 343 T why do B cells produce CD40 ligand? 328 T cell activation protein kinases requirements for interleukin-4 induction 283 fibroblast growth factor receptor interaction with Lck T cell receptors and nuclear factor of activated T cells 440 fibroblast growth factor receptor interaction with Lck protozoan parasites and nuclear factor of activated T cells 440 DNA-priming protein-boosting immunization 121 interleukin-2 prolongs postactivational refractoriness 8 T cells Q innate mechanism in xenograft rejection 451 quinolinic acid integrins and selectins in arthritis 397 tryptophan and the immune response 247 interleukin-2 prolongs postactivational refractoriness 8 T-cell apoptosis in Mycobacterium avium infection 480 T helper 1 R circadian macrophage inhibitory factor rhythm 137 rat T helper 2 cells plasma cells in rat yolk sac 335 interleukin-4 suppresses induction of early delayed type reciprocal antigen presentation hypersensitivity 424 reciprocal lysis of cytotoxic T-cells 266 circadian macrophage inhibitory factor rhythm 137 reciprocal lysis T lymphocytes reciprocal lysis of cytotoxic T-cells 266 thymic output and naive proliferation 487 recombinant allergen Thl1 response grass pollen immunotherapy vaccines 86 CC chemokine receptor | mediating susceptibility to recombinant protein Leishmania major 114 DNA-priming protein-boosting immunization 121 Th2 response recruitment CC chemokine receptor | mediating susceptibility to innate mechanism in xenograft rejection 451 Leishmania major 114 resistance evolution thymus evolution of immunocontraception resistance 152 thymic output and naive proliferation 487 rheumatoid arthritis T-lymphocytes drug treatment for rheumatoid arthritis and systemic flavivirus decoys the immune response 207 lupus erythematosus 350 tolerance FcyRIla as an inflammatory mediator 374 tryptophan and the immune response 247 molecular targets in rheumatoid arthritis 354 transcription factors ribonucleic acid vaccine fibroblast growth factor receptor interaction with Lck Kunjin replicon ribonucleic acid as a vaccine 73 and nuclear factor of activated T cells 440 ribonucleic acid virus transporter associated with antigen processing flavivirus evasion of the immune system 196 major histocompatibility complex class | up-regulation rolling by flaviviruses 217 leucocyte recruitment in systemic lupus erythematosus- treatments prone mice 390 drug treatment for rheumatoid arthritis and systemic lupus erythematosus 350 Ss tryptophan dioxygenase selectins tryptophan and the immune response 247 leucocyte recruitment in systemic lupus erythematosus- tumour immunity prone mice 390 cytotoxic T lymphocyte responses to melanoma cell signal transduction vaccines 459 fibroblast growth factor receptor interaction with Lck tumour immunotherapy and nuclear factor of activated T cells 440 aspects of cancer immunotherapy 79 signalling in mutant B lymphoma lines 297 tumour necrosis factor stromal cells molecular targets in rheumatoid arthritis 354 in vitro development of dendritic cells 144 tumour necrosis factor-a subunit vaccines differentiation and tumour necrosis factor-a in PLB improving vaccines against tuberculosis 34 chronic granulomatous disease cells 472 Subject index mucosal vascular addressin cell adhesion molecule-1 Ww outside the endothelial lineage 320 WASp tumour X-linked thrombocytopenia macrophages show determination of cytotoxic T lymphocyte epitopes 1 attenuated Wiskott-Aldrich syndrome phenotype 130 type | allergy West Nile virus grass pollen immunotherapy vaccines 86 flavivirus decoys the immune response 207 type 2 immunity oligoadenylate synthetase 1b protein provides protection listeria species and interleukin-4 deactivation 431 against West Nile virus 230 Wiskott-Aldrich syndrome Vv X-linked thrombocytopenia macrophages show vaccination attenuated Wiskott-Aldrich syndrome phenotype cytotoxic T lymphocyte responses to melanoma cell vaccines 459 X vaccine xenotransplantation aspects of cancer immunotherapy 79 innate mechanism in xenograft rejection 451 bacterial otitis media 46 X-linked thrombocytopenia epidermal powder immunization, hepatitis B surface X-linked thrombocytopenia macrophages show antigen 52 attenuated Wiskott-Aldrich syndrome phenotype 130 immunization using poly e-caprolactone microparticles 185 Y reducing antigen dose with cystosine guanine yolk sac dinucleotide-containing oligodeoxynucleotide as plasma cells in rat yolk sac 335 adjuvant 59 vaccines determination of cytotoxic T lymphocyte epitopes |